Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Vaccination of Acute Leukemia Patients with WT1 Peptide-Pulsed Dendritic Cells Induces Immunological and Clinical Responses: A Pilot Study

Shuichi Ota, MD PhD, Masahiro Ogasawara

Blood (2014) 124 (21): 2319.

https://doi.org/10.1182/blood.V124.21.2319.2319

Published: 2014

Journal Articles

Bifunctional Immunoactive siRNAs as an Approach to Personalized AML Therapy

Hanna Meinl, Marcus Zeitlhöfler, Samet Kocabey, Tim Liedl, PhD, Wolfgang Hiddemann, M.D., Marion Subklewe, MD, Stefan Endres, MD, Simon Rothenfußer, MD, Felix S Lichtenegger, MD

Blood (2013) 122 (21): 5036.

https://doi.org/10.1182/blood.V122.21.5036.5036

Published: 2013

Journal Articles

Vaccination Of Malignant Lymphoma Patients With WT1 Peptide-Pulsed Dendritic Cells Induces Immunological and Clinical Responses: A Pilot Study

Shuichi Ota, MD, PhD, Masahiro Ogasawara, MD, PhD

Blood (2013) 122 (21): 4403.

https://doi.org/10.1182/blood.V122.21.4403.4403

Published: 2013

Journal Articles

Human Papillomavirus Type 16 (HPV16) E6/E7-Specific Cytotoxic T Lymphocytes (CTLs) for Immunotherapy of HPV-Associated Malignancies

Carlos A. Ramos, MD, Neeharika Narala, MSc, Ann M. Leen, PhD, Ulrike Gerdemann, MD, Matthew L. Anderson, MD, PhD, Erich M. Sturgis, MD, MPH, Barbara Savoldo, MD, PhD, Helen E. Heslop, MD, Malcolm K. Brenner, MD, PhD, Cliona M. Rooney, PhD

Blood (2011) 118 (21): 1913.

https://doi.org/10.1182/blood.V118.21.1913.1913

Published: 2011

Journal Articles

Superior Immunogenicity of Idiotype Fab Fragments As Compared to Entire Immunoglobulin for Active Lymphoma Immunotherapy

Marcelo A. Navarrete, M.D., Benjamin Kisser, Hendrik J. Veelken, MD, PhD

Blood (2011) 118 (21): 1633.

https://doi.org/10.1182/blood.V118.21.1633.1633

Published: 2011

Journal Articles

RORing T cells target CLL and MCL

Michel Sadelain

Blood (2010) 116 (22): 4387–4388.

https://doi.org/10.1182/blood-2010-09-303388

Published: 2010

Journal Articles

H1N1-09 Infections In Patients with Hematologic or Oncologic Malignancies: A Single-Centre Experience

Nona Shayegi, Katja Sockel, Christoph Pöhlmann, Michael Laniado, Martin Bornhaeuser, Gerhard Ehninger, Johannes Schetelig

Blood (2010) 116 (21): 4866.

https://doi.org/10.1182/blood.V116.21.4866.4866

Published: 2010

Journal Articles

Analysis of Antigen-Specific T-Cell Responses and Regulatory T Cells Following Sibling Donor Immunization with Patient-Derived Idiotype Vaccine Prior to Non-Myeloablative Allogeneic Stem Cell Transplantation for Multiple Myeloma.

Myriam Foglietta, MD, Sattva Neelapu, M.D., Daniel H. Fowler, Seth M. Steinberg, Larry W. Kwak, Michael R. Bishop

Blood (2009) 114 (22): 2250.

https://doi.org/10.1182/blood.V114.22.2250.2250

Published: 2009

Journal Articles

Adoptive Cell Therapy for Lymphoma: Use of CpG-Loaded Tumor Cells to Generate Potent Anti-Tumor CD4 T Cell Immunity.

Matthew J Goldstein, Bindu Varghese, PhD, Ranjani Rajapaksa, PhD, Joshua Brody, MD, Shoshana Levy, PhD, Ronald Levy, MD

Blood (2009) 114 (22): 929.

https://doi.org/10.1182/blood.V114.22.929.929

Published: 2009

Journal Articles

Response Is Seen to Conjugate Vaccine but Not to Polysaccharide Vaccine Twelve Months After Rituximab.

Magnus Svensson, Ulrika Dahlin, Eva Kimby

Blood (2009) 114 (22): 2728.

https://doi.org/10.1182/blood.V114.22.2728.2728

Published: 2009

Journal Articles

Prediction of MHC Class I-Restricted Immunogenic Epitopes of B-Cell Receptors Indicates T Cell-Mediated Immunosurveillance of Malignant B Cell Clones.

Anna-Maria Strothmeyer, Marcus Duehren-von Minden, MSc, Marcelo A Navarrete, MD, Kristina Heining-Mikesch, MD, Hendrik Veelken, MD

Blood (2009) 114 (22): 1949.

https://doi.org/10.1182/blood.V114.22.1949.1949

Published: 2009

Journal Articles

Idiotype Vaccination of Untreated Indolent B-Cell Lymphoma: Durable Objective Remissions and Association of Superior Outcome with Cellular Immune Responses

Marcelo A. Navarrete, MD, Kristina Heining-Mikesch, MD, Cristina Bertinetti-Lapatki, PhD, Marcus Duehren-von Minden, Andrea Hafkemeyer, MD, Hendrik Veelken, MD

Blood (2008) 112 (11): 235.

https://doi.org/10.1182/blood.V112.11.235.235

Published: 2008

Journal Articles

A Placebo-Controlled Phase III Trial of Patient-Specific Immunotherapy with Mitumprotimut-T (ID-KLH) and GM-CSF Following Rituximab in Patients with CD20+ Follicular Lymphoma

Arnold S. Freedman, MD, Sattva Neelapu, MD, Craig R Nichols, MD, Michael Robertson, MD, Benjamin Djulbegovic, MD, PhD, Jane N. Winter, MD, Daniel Gold, PhD, John Bender, PharmD, Morgan Stewart, PhD, Richard G. Ghalie, MD, MBA, Paul A. Hamlin, Jr., MD

Blood (2008) 112 (11): 236.

https://doi.org/10.1182/blood.V112.11.236.236

Published: 2008

Journal Articles

Human Langerhans-Type Dendritic Cells Break Tolerance against the Tumor Antigen, WT1, by a Largely IL-15-Dependent Mechanism.

Emanuela Romano, MD, Rosa Barreira da Silva, BS, Sharanya Chandrasekar, MS, Christian Münz, PhD, Glenn Heller, PhD, James W. Young, MD

Blood (2008) 112 (11): 1554.

https://doi.org/10.1182/blood.V112.11.1554.1554

Published: 2008

Journal Articles

Keeping the barbarian at the gate

George K. Lewis

Blood (2006) 107 (8): 3020.

https://doi.org/10.1182/blood-2006-01-0425

Published: 2006

Journal Articles

Cloning of B Cell Lymphoma-Associated Antigens Using Modified Phage Displayed Expression cDNA Library and Immune Patient Sera.

Soung-chul Cha, PhD, Arya Biragyn, Ph.D, Pier Adelchi Ruffini, MD, Hong Qin, MD, Ph.D, Sattva S. Neelau, MD, Larry W. Kwak, MD, Ph.D

Blood (2005) 106 (11): 977.

https://doi.org/10.1182/blood.V106.11.977.977

Published: 2005

Journal Articles

In Vitro Expansion of Autologous Follicular Lymphoma-Specific T Cells for Adoptive Transfer.

Seung-Tae Lee, MD, Yun Fang Jiang, MD, Ph.D, Soung-Chul Cha, Ph.D, Hong Qin, MD, Ph.D, Larry W. Kwak, MD, Ph.D, Sattva S. Neelapu, MD

Blood (2005) 106 (11): 1482.

https://doi.org/10.1182/blood.V106.11.1482.1482

Published: 2005

Journal Articles

GD2 Peptide Mimotope DNA Vaccines for Anti-Neuroblastoma Immunotherapy.

Stefan Fest, MD, Kerstin Hilt, Nicole Huebener, Yan Zeng, MD, Anne Strandsby, Silke Weixler, MD, Gerhard Gaedicke, MD, Angelika Riemer, MD, Elisabeth Foerster-Waldl, MD, Erika Jensen-Jarolim, MD, Holger N. Lode, MD

Blood (2004) 104 (11): 1350.

https://doi.org/10.1182/blood.V104.11.1350.1350

Published: 2004

Journal Articles

Characterization of Cellular Immune Responses to a Recombinant Idiotype Vaccine by ELISPOT and Identification of MHC Class I-Restricted T Cell Epitopes by Peptide Mapping.

Cristina M. Bertinetti, PhD, Hendrik Veelken, MD

Blood (2004) 104 (11): 1409.

https://doi.org/10.1182/blood.V104.11.1409.1409

Published: 2004

Journal Articles

Development of Cell Based Therapeutic Vaccines for the Treatment of Multiple Myeloma.

Renata J. Walewska, MRCPath, Deborah J. Dunnion, PhD, K. J. Pasi, FRCPath, Michael J. Browning, FRCPath

Blood (2004) 104 (11): 1494.

https://doi.org/10.1182/blood.V104.11.1494.1494

Published: 2004

NARROW

Vaccination of Acute Leukemia Patients with WT1 Peptide-Pulsed Dendritic Cells Induces Immunological and Clinical Responses: A Pilot Study

Bifunctional Immunoactive siRNAs as an Approach to Personalized AML Therapy

Vaccination Of Malignant Lymphoma Patients With WT1 Peptide-Pulsed Dendritic Cells Induces Immunological and Clinical Responses: A Pilot Study

Human Papillomavirus Type 16 (HPV16) E6/E7-Specific Cytotoxic T Lymphocytes (CTLs) for Immunotherapy of HPV-Associated Malignancies

Superior Immunogenicity of Idiotype Fab Fragments As Compared to Entire Immunoglobulin for Active Lymphoma Immunotherapy

RORing T cells target CLL and MCL

H1N1-09 Infections In Patients with Hematologic or Oncologic Malignancies: A Single-Centre Experience

Analysis of Antigen-Specific T-Cell Responses and Regulatory T Cells Following Sibling Donor Immunization with Patient-Derived Idiotype Vaccine Prior to Non-Myeloablative Allogeneic Stem Cell Transplantation for Multiple Myeloma.

Adoptive Cell Therapy for Lymphoma: Use of CpG-Loaded Tumor Cells to Generate Potent Anti-Tumor CD4 T Cell Immunity.

Response Is Seen to Conjugate Vaccine but Not to Polysaccharide Vaccine Twelve Months After Rituximab.

Prediction of MHC Class I-Restricted Immunogenic Epitopes of B-Cell Receptors Indicates T Cell-Mediated Immunosurveillance of Malignant B Cell Clones.

Idiotype Vaccination of Untreated Indolent B-Cell Lymphoma: Durable Objective Remissions and Association of Superior Outcome with Cellular Immune Responses

A Placebo-Controlled Phase III Trial of Patient-Specific Immunotherapy with Mitumprotimut-T (ID-KLH) and GM-CSF Following Rituximab in Patients with CD20+ Follicular Lymphoma

Human Langerhans-Type Dendritic Cells Break Tolerance against the Tumor Antigen, WT1, by a Largely IL-15-Dependent Mechanism.

Keeping the barbarian at the gate

Cloning of B Cell Lymphoma-Associated Antigens Using Modified Phage Displayed Expression cDNA Library and Immune Patient Sera.

In Vitro Expansion of Autologous Follicular Lymphoma-Specific T Cells for Adoptive Transfer.

GD2 Peptide Mimotope DNA Vaccines for Anti-Neuroblastoma Immunotherapy.

Characterization of Cellular Immune Responses to a Recombinant Idiotype Vaccine by ELISPOT and Identification of MHC Class I-Restricted T Cell Epitopes by Peptide Mapping.

Development of Cell Based Therapeutic Vaccines for the Treatment of Multiple Myeloma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only